Pharma Company Biokin Considers $432 Million Initial Public Offering in Hong Kong Amid Increased Fundraising Activity


Source: ChinaMoneyNetwork.com ChinaMoneyNetwork.com

Key Topics in this News Article:

News Snapshot: